東譽興業股份有限公司

主成分
Lithium Carbonate contains not less than 98.0% and not more than 102.0% of lithium carbonate(Li2CO3), calculated on the dried basis. 
適應症
治療憂鬱藥
主成分
Policresulen solution contains not less than 45.5% w/w and not more than 54.5% w/w of C23H24O12S3. 
適應症
抗菌劑
主成分
Erythromycin estolate contains not less than 600 μg of erythromycin (C37H67NO13) per mg, calculated on the anhydrous basis. 
適應症
抗生素
主成分
Mometasone Furoate contains not less than 97.0% and not more than 102.0% of C27H30CI2O6 calculated on the dried substance. 
適應症
腎上腺皮質類固醇
主成分
Atorvastatin Calcium Trihydrate contains not less than 98.0% and not more than 102.0% of (C33H34FN2O5)2 Ca‧3H2O, calculated on the anhydrous basis. 
適應症
高膽固醇血症、高三酸甘油脂血症。
主成分
Fluvoxamine Maleate contains not less than 99.0% and not more than 101.0% of C19H25F3N2O6, calculated on the dried substance. 
適應症
治療憂鬱藥
主成分
Desloratadine contains not less than 98.0% and not more than 102.0% of C19H19ClN2, calculated on the anhydrous basis. 
適應症
抗組織胺劑
主成分
Quetiapine Fumarate contains not less than 99.0% and not more than 101.0% of (C21H25N3O2S)2, C4H4O4 calculated on the dried substance. 
適應症
思覺失調症、雙極性疾患之躁症發作。
主成分
Clozapine contains not less than 98.0% and not more than 102.0% of C18H19ClN4 calculated on the dried basis. 
適應症
思覺失調症。
主成分
Lercanidipine Hydrochloride contains not less than 98.0% and not more than 102.0% of C36H42ClN3O6, calculated on the dried basis. 
適應症
抗高血壓劑
主成分
Glimepiride contains not less than 97.0% and not more than 102.0% of C24H34N4O5S, calculated on the anhydrous substance. 
適應症
非胰島素依賴型(第二型)糖尿病
主成分
Milnacipran Hydrochloride contains not less than 99.0% and not more than 101.0% of C15H23ClN2O, calculated on the anhydrous basis. 
適應症
抗抑鬱劑
主成分
Bilastine (Form-I) contains not less than 98.0% and not more than 102.0% of C28H37N3O3, calculated on the anhydrous basis. 
適應症
抗組織胺藥
主成分
Chlorzoxazone contains not less than 98.0% and not more than 102.0% of C7H4ClNO2 calculated on the dried substance. 
適應症
骨骼肌鬆弛劑。
主成分
Nintedanib Esylate contains not less than 98.0 % and not more than 102.0 % of C31H33N5O4‧C2H6O3S, calculated on the anhydrous basis. 
適應症
特發性肺纖維化
主成分
Chlorzoxazone contains not less than 98.0% and not more than 102.0% of C7H4ClNO2, calculated on the anhydrous basis. 
適應症
骨骼肌鬆弛劑
主成分
Benserazide Hydrochloride contains not less than 98.5% and not more than 101.0% of C10H16ClN3O5, calculated on the anhydrous substance. 
適應症
帕金森氏症。
主成分
Fluticasone Propionate contains not less than 97.5% and not more than 102.0% of C25H31F3O5S, calculated on the anhydrous substance. 
適應症
抗炎性皮質固醇(外用)
主成分
Ciprofloxacin contains not less than 99.0% and not more than 101.0% of C17H18FN3O3, calculated on the dried substance. 
適應症
抗菌藥
主成分
Deferasirox contains not less than 98.0 % and not more than 102.0 % of C21H15N3O4, calculated on dried basis. 
適應症
排鐵劑
主成分
Sildenafil Citrate contains NLT 98.0% and NMT 102.0% of sildenafil citrate (C22H30N6O4S.C6H8O7), calculated on the anhydrous and solvent-free basis. 
適應症
男性勃起障礙治療
主成分
Levetiracetam contains not less than 98.0% and not more than 102.0% of C8H14N2O2, calculated on the anhydrous basis. 
適應症
抗癲癇藥
主成分
Azathioprine (Process 2) contains not less than 98.5% and not more than 101.0% of C9H7N7O2S, calculated on anhydrous basis. 
適應症
免疫抑制及調節劑
主成分
Flurbiprofen contains not less than 99.0% and not more than 101.0% of C15H13FO2, calculated on the dried substance. 
適應症
消炎藥、鎮痛藥
主成分
Sodium Valproate contains not less than 98.5% and not more than 101.0% of C8H15NaO2, calculated on the dried substance. 
適應症
抗癲癇藥物
主成分
Ubidecarenone contains not less than 98.0% and not more than 102.0% of C59H90O4, calculated on the anhydrous basis. 
適應症
膳食補充劑
主成分
Lacosamide contains not less than 98.0% and not more than 102.0% of C13H18N2O3, calculated on the anhydrous substance. 
適應症
抗癲癇藥
主成分
Atorcastatin Calcium Trihydrate contains not less than 97.0% and not more than 102.0% of C66H68CaF2N4O10‧3H2O calculated on the anhydrous substance. 
適應症
降血脂藥
主成分
Ramipril con tains not less than 98.0% and not more than 102.0% of C23H32N2O5 calculated on the dried substance. 
適應症
高血壓。
主成分
Diluted Isosorbide-5-Mononitrate is a dry mixture of isosorbide mononitrate and Lactose monohydrate or Mannitol. It contains not less than 95.0% and not more than 105.0% C6H9NO6, calculated with reference to the dried substrance. 
適應症
預防狹心症發作。
主成分
Pramipexole HCl (Pramipexole Di-HCl Monohydrate) contains not less than 98.0% and not more than 102.0% of C10H19Cl2N3S, calculated on the anhydrous basis. 
適應症
抗巴金森氏症
主成分
Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C28H38N6O11S calculated on the dried substance. 
適應症
成年男性勃起功能障礙。
主成分
Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2,calculated on the dried basis. 
適應症
思覺失調症。
主成分
Diluted Isosorbide-5-Mononitrate (80%) is a dry mixture of isosorbide mononitrate and Lactose monohydrate. It contains not less than 76.0% m/m and not more than 84.0% m/m of the content of 1, 4:3, C6H9NO6 stated on the label. 
適應症
預防狹心症之發作。
主成分
Glimepiride contains not less than 98.0% and not more than 102.0% of C24H34N4O5S, calculated on the anhydrous basis. 
適應症
非胰島素依賴型(第二型)糖尿病。
主成分
Levetiracetam contains not less than 98.0% and not more than 102.0% of C8H14N2O2 calculated on the anhydrous and solvent-free basis. 
適應症
十六歲以上病患之局部癲癇發作(併有或不併有次發性全身發作)之單獨治療。四歲以上孩童或成人病患之局部癲癇發作(併有或不併有次發性全身發作),十二歲以上青少年與成人病患之肌抽躍性癲癇發作,以及十六歲以上青少年與成人患有體質性泛發性癲癇的原發性泛發性強直陣孿發作之輔助治療。
主成分
Polysaccharide Iron Complex is a combination of saccharide and iron. It contains not less than 44.5% and not more than 47.5% of iron. 
適應症
單純性鐵缺乏之貧血症。
主成分
Lornoxicam contains not less than 98.0% and not more than 102.0% of C13H10ClN3O4S2 calculated on the dried basis. 
適應症
輕度至中度急性疼痛之短期止痛。
主成分
Venlafaxine HC1 contains not less than 99.0% and not more than 101.0% of C17H28C1NO2 calculated on dried substance. 
適應症
憂鬱症、泛焦慮症。
主成分
Diosmin contains not less than 90.0% and not more than 102.0% of C28H32O15, calculated on the anhydrous substance. 
適應症
協助改善慢性靜脈功能不全引起之局部腫脹或疼痛、痔瘡症狀之緩解。
主成分
Dibucaine contains not less than 97.0% and not more than 102.5% of C20H29N3O2, calculated on the dried basis.  
適應症
局部麻醉藥
主成分
Policresulen 50% solution contains not less than 45.0% w/w and not more than 55.0% of C23H24O12S3 
適應症
抗菌劑
主成分
Atorvastatin calcium trihydrate (Form I ) contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10‧3H2O on the anhydrous and solvent-free basis. 
適應症
高膽固醇血症、高三酸甘油脂血症。
主成分
Dry mixture of isosorbide mononitrate and Lactose monohydrate or Mannitol. It contains not less than 95.0% and not more than 105.0% 1,4:3,6-dianhydro-D-glucitol 5-nitrate(C6H9NO6) stated on the label 
適應症
預防狹心症之發作。
主成分
Valproic Acid contains not less than 99.0% and not more than 101.0% of C8H16O2. 
適應症
抗癲癇藥
主成分
Risperidone contains not less than 99.0% and not more than 101.0% of C23H27FN4O2, calculated on the dried substance. 
適應症
抗精神病藥
主成分
Azathioprine contains not less than 98.0% and not more than 101.5% of C9H7N7O2S calculated on the dried basis. 
適應症
免疫抑制及調節劑
主成分
Risperidone contains not less than 99.0% and not more than 101.0% of C23H27FN4O2 calculated on the dried basis.  
適應症
精神異常引起之相關症狀劑。